What polypharmacy recommendations (drugdrug interactions, gaps, and omissions) should be made for a patient with type 1 and type 2 diabetes on insulin aspart 46.5 units daily and insulin lispro 55.6 units daily, sertraline 25 mg daily, hydrocodone/acetaminophen 5 mg/325 mg three times daily, hydroxyzine 10 mg daily, esomeprazole 40 mg twice daily, dupilumab 300 mg every two weeks, cholecalciferol (vitamin D) 0.05 mg daily, multiple topical agents, blood pressure 154/84 mm Hg without antihypertensive therapy, and irondeficiency anemia with melena?
An innovative formula to combat oxidative stress: S-acetyl glutathione escapes oxidation in the intestine and maximises its bioavailability to effectively penetrate the cells of the human body
The Fix: Be patient
doi: 10.1155/2021/5582245
Investigating claims on behalf of more than 2,000 plaintiffs is Mount Pleasant-based law office Motley Rice LLC, which has been on the forefront of litigation against pharmaceutical companies, Novo Nordisk and Eli Lilly, alleging that prescribed patients aren't adequately apprised of the adverse effects of the GLP-1 drugs in question
